Literature DB >> 30652002

Fulminant pseudomembranous enterocolitis caused by Klebsiella oxytoca: an autopsy case report.

Tatsunori Nagamura1, Yoshihiro Tanaka1, Takero Terayama1, Daishi Higashiyama1, Soichiro Seno1, Naoaki Isoi1, Yuka Katsurada2, Akiko Matsubara3, Yuya Yoshimura1, Yasumasa Sekine1, Shinji Akitomi1, Kimiya Sato4, Hitoshi Tsuda4, Daizoh Saitoh1, Hisashi Ikeuchi1.   

Abstract

CASE: We describe a rare case of antibiotic-associated fulminant pseudomembranous enterocolitis caused by Klebsiella oxytoca. A 79-year-old man with a history of antibiotic therapy was admitted to our emergency department, complaining of consciousness disturbance. Initially, we suspected septic shock and diabetic ketoacidosis caused by intestinal infection. Although we administered sufficient extracellular fluid, his blood pressure was not elevated and his abdomen gradually swelled. OUTCOME: The patient died of shock and abdominal compartment syndrome. Autopsy revealed widespread jejunal necrosis in conjunction with colitis, suggesting fulminant pseudomembranous enterocolitis caused by K. oxytoca infection.
CONCLUSION: As the clinical features of pseudomembranous enterocolitis caused by K. oxytoca resemble the features of colitis caused by Clostridium difficile, conservative therapy is applied first. However, fulminant pseudomembranous enterocolitis is a lethal disease, necessitating early operation for resection of the necrotic lesion. This report highlights the need for better surgical criteria at an early stage.

Entities:  

Keywords:  Abdominal compartment syndrome; Clostridium difficile; Klebsiella oxytoca; inflammatory bowel disease; septic shock

Year:  2018        PMID: 30652002      PMCID: PMC6328918          DOI: 10.1002/ams2.370

Source DB:  PubMed          Journal:  Acute Med Surg        ISSN: 2052-8817


Introduction

Drug‐associated diarrhea frequently occurs during antibiotic treatment. Clostridium difficile is a spore‐forming gram‐positive bacterium, and the clinical spectrum of C. difficile infection ranges from simple diarrhea without severe colitis to pseudomembranous colitis and fulminant colitis.1 Some types of pseudomembranous colitis infrequently occur in close association with ischemic colitis or infections by organisms such as cytomegalovirus, Shigella dysenteriae, Escherichia coli O157:H7, and Klebsiella oxytoca.2 Klebsiella oxytoca is a gram‐negative bacterium that provokes bacteremia, septic shock coupled with systemic organ dysfunction, and even death in serious cases.3 In 2006, K. oxytoca was first reported as a cause of antibiotic‐associated hemorrhagic colitis.4 However, to our knowledge, no case report has determined that K. oxytoca causes antibiotic‐associated fulminant pseudomembranous enterocolitis. Herein, we describe a rare case of antibiotic‐associated fulminant pseudomembranous enterocolitis caused by K. oxytoca.

Case

A 79‐year‐old man with diabetes mellitus was admitted to our emergency department with a complaint of consciousness disturbance. He received clarithromycin 400 mg/day to treat diarrhea before admission. On arrival, his vital signs were as follows: Glasgow Coma Scale score, E4V1M1; blood pressure, 144/102 mmHg; heart rate, 85 b.p.m.; respiratory rate, 25 cycles/min; peripheral oxygen saturation (SpO2) of 100%, with a 10 L/min oxygen reservoir mask. Blood gas analysis findings were as follows: pH, 7.219; PaCO2, 59.4 mmHg; PaO2, 529 mmHg; , 20.4 mEq/L; base excess, −3.3 mEq/L. Severe respiratory and mild metabolic acidosis with hyperglycemia (glucose, 491 mg/dL) were also noted. Because we initially suspected diabetic ketoacidosis and severe hypoventilation, we promptly intubated the patient and initiated the simultaneous i.v. injection of Ringer's lactate solution and regular insulin (8 IU). Serum examination strongly indicated renal dysfunction (blood urea nitrogen, 74 mg/dL; creatinine, 2.96 mg/dL), hyperkalemia (potassium, 5.3 mEq/L), and marked inflammatory reaction (C‐reactive protein, 15.6). Computed tomography revealed no abnormal lesions in the brain; however, marked intestinal dilation and swelling were observed between the duodenum and jejunum. These findings led to an initial diagnosis of septic shock and diabetic ketoacidosis caused by intestinal infection. Despite sufficient extracellular fluid, his blood pressure was not elevated and his abdomen gradually swelled (Fig. 1A). Contrast‐enhanced computed tomography revealed intestinal dilatation but no sign of ischemia or necrosis (Fig. 1B,C). Physiological examination (intra‐abdominal pressure >50 mmHg) also clearly showed abdominal compartment syndrome. We attempted an emergency operation, but the patient's condition deteriorated so rapidly that we could not ameliorate his hemodynamics. Finally, he died of shock and abdominal compartment syndrome 10 h after admission.
Figure 1

Time course and imaging findings of a 79‐year‐old man with fulminant pseudomembranous enterocolitis caused by Klebsiella oxytoca. A, Schema of the patient's clinical time course (min) from admission to death. ICU, intensive care unit; NAD (γ), nor‐adrenaline (mg/kg/min); PEA, pulseless electrical activity; sBP, systolic blood pressure. B,C, Contrast‐enhanced computed tomography scan (6 h after admission). Arrows indicate intestinal dilatation and swelling, with the fluid level between the duodenum and the jejunum. However, there were no signs of ischemia or necrosis because the intestinal wall was well‐enhanced with contrast media.

Time course and imaging findings of a 79‐year‐old man with fulminant pseudomembranous enterocolitis caused by Klebsiella oxytoca. A, Schema of the patient's clinical time course (min) from admission to death. ICU, intensive care unit; NAD (γ), nor‐adrenaline (mg/kg/min); PEA, pulseless electrical activity; sBP, systolic blood pressure. B,C, Contrast‐enhanced computed tomography scan (6 h after admission). Arrows indicate intestinal dilatation and swelling, with the fluid level between the duodenum and the jejunum. However, there were no signs of ischemia or necrosis because the intestinal wall was well‐enhanced with contrast media. In autopsy, thinning, petechiae, and intestinal dilation were observed from the ligament of Treitz to 100 cm caudal to the jejunum. Pseudomembrane formation was observed on the intestinal mucosa (Fig. 2B). On histological analysis, severe inflammatory cell infiltration was observed in the lung, trachea, esophagus, liver, and spleen. In addition, hemophagocytosis was also observed in the bone marrow, indicating that systemic inflammation clearly occurred because of sepsis.
Figure 2

Autopsy findings in a 79‐year‐old man with fulminant pseudomembranous enterocolitis caused by Klebsiella oxytoca. A, Images of intestinal necrosis in the autopsy. Mucosal necrosis is observed between the duodenum and jejunum (arrows). B, Intestinal necrosis is observed between the duodenum and jejunum. Arrows indicate pseudomembrane formation. C, Microscopic view. Hematoxylin–eosin staining (×40). D, High‐power view (×100) of (C). Hematoxylin–eosin staining reveals mucosal hemorrhagic necrosis and submucosal edema in conjunction with pseudomembranous formation. E, Maximum‐power view (×1,000) of (C). Arrows indicate gram‐negative bacilli that correspond to K. oxytoca.

Autopsy findings in a 79‐year‐old man with fulminant pseudomembranous enterocolitis caused by Klebsiella oxytoca. A, Images of intestinal necrosis in the autopsy. Mucosal necrosis is observed between the duodenum and jejunum (arrows). B, Intestinal necrosis is observed between the duodenum and jejunum. Arrows indicate pseudomembrane formation. C, Microscopic view. Hematoxylin–eosin staining (×40). D, High‐power view (×100) of (C). Hematoxylin–eosin staining reveals mucosal hemorrhagic necrosis and submucosal edema in conjunction with pseudomembranous formation. E, Maximum‐power view (×1,000) of (C). Arrows indicate gram‐negative bacilli that correspond to K. oxytoca. Gram‐negative bacilli were histologically detected in close association with the pseudomembrane. The mucous membrane was completely destroyed and replaced with inflammatory cell filtration, submucosal edema, and cellular debris (Fig. 2C,D). Klebsiella oxytoca was also identified by a post‐mortem bacterial culture from pseudomembranous contents of the jejunum. The patient had received clarithromycin before admission. Furthermore, the only bacterium cultured from the patient's first sputum was K. oxytoca, suggesting that K. oxytoca infection was already present on the day of admission. Therefore, our final diagnoses were as follows: (i) fulminant pseudomembranous enterocolitis caused by K. oxytoca, (ii) septic shock, (iii) diabetic ketoacidosis, (iv) abdominal compartment syndrome.

Discussion

To the best of our knowledge, this paper is the first autopsy report on fulminant pseudomembranous enterocolitis caused by K. oxytoca. The symptoms of K. oxytoca‐induced colitis resemble those of C. difficile‐induced colitis, as both bacteria cause opportunistic infections in immunocompromised hosts. In particular, our case clearly differed from previous cases because all damage was localized not in the colon but in the jejunum. To our knowledge, to date, only two case reports on pseudomembranous colitis caused by K. oxytoca 2, 5 have been published (Table 1). Conservative therapy following the cessation of prescribed medication was selected as the initial treatment in both cases.
Table 1

Published case reports of pseudomembranous colitis caused by Klebsiella oxytoca

Author (year)Tomita et al. (1984)Sweetser et al. (2002)Our case (2018)
DiagnosisPseudomembranous colitisPseudomembranous colitisFulminant pseudomembranous enterocolitis
Age, years; gender15, male67, female79, male
AntibioticCefatrizineUnknownClarithromycin
SymptomsDiarrhea, melenaWatery diarrheaDiarrhea
Lesion20–45 cm from the anal ringSigmoid colon100 cm distal from ligament of Treitz
TreatmentConservative MetronidazoleConservative
ResultSurvivalSurvivalDeath
Published case reports of pseudomembranous colitis caused by Klebsiella oxytoca The mechanisms of K. oxytoca‐induced antibiotic‐associated enterocolitis are still controversial because K. oxytoca has no enterotoxin. In C. difficile‐induced pseudomembranous colitis, toxin A plays a key role as an enterotoxin. In K. oxytoca, tilivalline and kleboxymycin (precursor of tilivalline) play roles as cytotoxins.6, 7 We could not find any scientific papers published to date that reference fulminant pseudomembranous enterocolitis caused by K. oxytoca. We believe that the pathogen causing pseudomembranous enterocolitis was K. oxytoca because of two factors. First, histology apparently revealed severe inflammation due to K. oxytoca infection (Fig. 2). Second, the bacteriological culture from the patient's sputum and post‐mortem contents from the jejunal pseudomembrane also showed K. oxytoca bacterial growth, suggesting that septic shock occurred because of fulminant enterocolitis caused by K. oxytoca infection. In addition, K. oxytoca often causes bacteremia when the patients are immunocompromised hosts, such as those with hepatopancreatic failure, malignant diseases, or diabetes mellitus.3 In our case, the patient's clinical condition might have become more serious because of uncontrolled diabetes mellitus. Fulminant pseudomembranous colitis should be suspected when patients show systemic signs of toxicity including fever, hypotension, tachycardia, leukocytosis, and severe dehydration that requires massive transfusion.8 Surgical treatment leads to better results than conservative therapy. Postoperative mortality after urgent colectomy was reported to range from 34% to 57%.9 Indications for surgery could include toxic megacolon, perforation and/or peritonitis, fulminant disease in the presence of septic shock, multiple organ failure, and failure of conservative therapy.9 In our case, we rapidly administered sufficient fluid but it was very difficult to stabilize the patient's hemodynamics. The patient's clinical course was so rapid that it made surgery impossible. We should have carried out an urgent operation as soon as his abdominal swelling was noted. However, it is difficult to predict the failure of conservative therapy in the early phase. Better criteria are required to aid surgery selection in the early phase of fulminant pseudomembranous colitis.

Conclusion

We reported a rare case of fulminant pseudomembranous enterocolitis caused by K. oxytoca infection. Fulminant pseudomembranous enterocolitis is lethal and early surgery is necessary if it is suspected. The treatment is restricted to an “early diagnosis–early operation” policy, although the basic mechanisms and essential treatment of this condition remain unknown.

Disclosure

Approval of the research protocol: N/A. Informed consent: Yes. Registry and the registration no. of the study/trial: N/A. Animal studies: N/A. Conflict of interest: N/A.
  8 in total

1.  Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis.

Authors:  Georg Schneditz; Jana Rentner; Sandro Roier; Jakob Pletz; Kathrin A T Herzog; Roland Bücker; Hanno Troeger; Stefan Schild; Hansjörg Weber; Rolf Breinbauer; Gregor Gorkiewicz; Christoph Högenauer; Ellen L Zechner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

2.  Pseudomembranous colitis secondary to Klebsiella oxytoca.

Authors:  Seth Sweetser; Kenneth W Schroeder; Darrell S Pardi
Journal:  Am J Gastroenterol       Date:  2009-09       Impact factor: 10.864

3.  Klebsiella oxytoca bacteremia causing septic shock in recipients of hematopoietic stem cell transplant: Two case reports.

Authors:  Khalid A Al-Anazi; Asma M Al-Jasser; Hazza A Al-Zahrani; Naem Chaudhri; Fahad I Al-Mohareb
Journal:  Cases J       Date:  2008-09-18

4.  Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.

Authors:  Ramsey M Dallal; Brian G Harbrecht; Arthur J Boujoukas; Carl A Sirio; Linda M Farkas; Kenneth K Lee; Richard L Simmons
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

Review 5.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

6.  Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis.

Authors:  Christoph Högenauer; Cord Langner; Eckhard Beubler; Irmgard T Lippe; Rudolf Schicho; Gregor Gorkiewicz; Robert Krause; Nikolas Gerstgrasser; Guenter J Krejs; Thomas A Hinterleitner
Journal:  N Engl J Med       Date:  2006-12-07       Impact factor: 91.245

7.  Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality.

Authors:  Elizabeth A Sailhamer; Katherine Carson; Yuchiao Chang; Nikolaos Zacharias; Konstantinos Spaniolas; Malek Tabbara; Hasan B Alam; Marc A DeMoya; George C Velmahos
Journal:  Arch Surg       Date:  2009-05

8.  A tricyclic pyrrolobenzodiazepine produced by Klebsiella oxytoca is associated with cytotoxicity in antibiotic-associated hemorrhagic colitis.

Authors:  Herman Tse; Qiangshuai Gu; Kong-Hung Sze; Ivan K Chu; Richard Y-T Kao; Kam-Chung Lee; Ching-Wan Lam; Dan Yang; Sherlock Shing-Chiu Tai; Yihong Ke; Elaine Chan; Wan-Mui Chan; Jun Dai; Sze-Pui Leung; Suet-Yi Leung; Kwok-Yung Yuen
Journal:  J Biol Chem       Date:  2017-09-26       Impact factor: 5.157

  8 in total
  5 in total

Review 1.  Klebsiella oxytoca and Emerging Nosocomial Infections.

Authors:  Nakul Neog; Upasana Phukan; Minakshi Puzari; Mohan Sharma; Pankaj Chetia
Journal:  Curr Microbiol       Date:  2021-03-03       Impact factor: 2.188

2.  Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.

Authors:  Jing Yang; Haiyan Long; Ya Hu; Yu Feng; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2021-12-01       Impact factor: 50.129

Review 3.  The Changing Face of the Family Enterobacteriaceae (Order: "Enterobacterales"): New Members, Taxonomic Issues, Geographic Expansion, and New Diseases and Disease Syndromes.

Authors:  J Michael Janda; Sharon L Abbott
Journal:  Clin Microbiol Rev       Date:  2021-02-24       Impact factor: 26.132

4.  Occurrence and determinants of Klebsiella species bloodstream infection in the western interior of British Columbia, Canada.

Authors:  Connor B Reid; Lisa Steele; Kelsey Pasquill; Elizabeth C Parfitt; Kevin B Laupland
Journal:  BMC Infect Dis       Date:  2019-12-19       Impact factor: 3.090

5.  Bacterial Indole as a Multifunctional Regulator of Klebsiella oxytoca Complex Enterotoxicity.

Authors:  Nagender Ledala; Mishika Malik; Karim Rezaul; Sara Paveglio; Anthony Provatas; Aaron Kiel; Melissa Caimano; Yanjiao Zhou; Jonathan Lindgren; Kristyna Krasulova; Peter Illes; Zdeněk Dvořák; Sandhya Kortagere; Sabine Kienesberger; Amar Cosic; Lisa Pöltl; Ellen L Zechner; Subho Ghosh; Sridhar Mani; Justin D Radolf; Adam P Matson
Journal:  mBio       Date:  2022-01-25       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.